(MedPage Today) -- Slight increases in serum creatinine levels were seen in a small number of rheumatoid arthritis patients treated with tofacitinib (Xeljanz) in phase III trials, but the clinical significance of the finding is uncertain. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment